CVS Health Corporation (NYSE:CVS) [Trend Analysis] hangs on to mix trends, as shares trade at $96.95 by declined -0.62% with volume of 6.71 Million shares that was impressive than its average volume of 4289.36 shares.
The retail medical clinic of CVS Health (NYSE:CVS), which operates over 1,100 retail medical clinics in CVS Pharmacy and Target stores across the United States, MinuteClinic has introduced a new digital tool that allows patients to view wait times at most locations and hold a place in line from the convenience of their smartphone, computer or tablet.
President of CVS MinuteClinic and Executive VP and Associate Chief Medical Officer of CVS Health, Andrew Sussman stated that since introducing first store-based, walk-in clinics in 2000, MinuteClinic has consistently developed new ways to evolve its model to make health care services more convenient for consumer. “We know patients are demanding added convenience as they interact with the health care system. The option to hold a place in line gives patients more choices and flexibility and will allow for prompt care when arriving at our clinics. We think of it as the ‘cure for the common wait’.”
For current month, 3 analyst from pool recommended for an “overweight” rating, while 19 gave rating of “Buy” and 4 analysts suggest to “Hold” and 1 gave preference to “underweight,” according to research rating by WSJ.
While alarming thing to be notice is price target, the average pool price target for CVS has been mentioned as; 123.00 tends to high price target, medium level touched to 115.00, and 104.00 was assigned as lowest share price targets. To accommodate all of these, average analyst price target appeared by 114.26, where as the current price is 96.95, as per research conducted by WSJ.
As the revenues measures, firm has operation margin of 5.90% in the following twelve months with net profit margin of positive 3.20%. The Company showed a positive 3.20% in the net profit margin and in addition to in its operating margin which remained 5.90%. Company’s annual sales growth for the past five year was 9.90%.
CVS Health Corporation (NYSE:CVS) presented weekly performance of -3.96% with respect to its rate of return and it remained -5.60% for the month. However, the performance for a quarter experienced change of -0.32% and its performance for a year is -4.61% and its year to date performance remained in green with 0.02%. The stock price volatility was 1.63% for a week and 1.72% for a month as well as price volatility’s Average True Range for 14 days was 1.66 and its beta remained 0.86.
Current stock price is in the upbeat territory taking into account of 20 days moving average with -5.28% and continued bullish run for 50 days moving average with -4.99%. Its earnings per share for the past twelve months were 16.80%. Company’s beta coefficient was at 0.86. Beta measures the amount of market risk associated with market trade.